Quipt Home Medical CORP 8-K filings

Quipt Home Medical Corp. has completed its acquisition by affiliates of Kingswood and Forager for US$3.65 per share, totaling approximately $173 million, transitioning to a privately held entity.

Quipt Home Medical Corp. shareholders overwhelmingly approved the plan of arrangement for its acquisition by affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC for US$3.65 per share.

Quipt Home Medical Corp. announced the expiration of the HSR Act waiting period, satisfying a key condition for its acquisition by Purchaser for $3.65 per share in cash.

Quipt Home Medical Corp. announced a special shareholder meeting on March 3, 2026, to vote on a proposed transaction involving 1567208 B.C. LTD and REM Aggregator, LLC.

Quipt Home Medical Corp. announced its fourth quarter and fiscal year 2025 financial results, showing strong Q4 revenue growth but a slight annual decline.

Quipt Home Medical Corp. has entered into a definitive agreement to be acquired by affiliates of Kingswood Capital Management and Forager Capital Management for US$3.65 per share in an all-cash transaction.

Quipt Home Medical Corp. confirmed its board rejected Forager Capital Management's latest unsolicited, non-binding acquisition proposal of US$3.10 per share, citing undervaluation and self-serving tactics.

Quipt Home Medical Corp. announced a definitive agreement to acquire a 60% ownership interest in Hart Medical Equipment, forming a strategic joint venture with major health systems.

Quipt Home Medical Corp. reported a return to positive organic growth and maintained strong Adjusted EBITDA margins in its fiscal third quarter 2025, alongside a strategic post-quarter acquisition.

Quipt Home Medical Corp. announced the acquisition of a Ballad Health-owned durable medical equipment provider with $6.6 million in revenue and a preferred provider agreement covering 20 hospitals, marking a significant strategic expansion.

Quipt Home Medical Corp. acknowledges receiving an unsolicited, non-binding acquisition proposal from Forager Capital Management, LLC to acquire 100% of the company's shares at $3.10 per share.

Quipt Home Medical Corp. announces its fiscal second quarter 2025 financial results, with revenue decreasing but Adjusted EBITDA remaining strong at 23.3% of revenue.

Quipt Home Medical unveils its 2025 strategic priorities, focusing on organic growth, capital allocation, and healthcare system partnerships, alongside announcing the results of its annual general meeting.

Quipt Home Medical Corp. held its annual general meeting on March 17, 2025, where shareholders elected directors and re-appointed auditors.

Quipt Home Medical Corp. and Kanen Wealth Management have entered into a cooperation agreement, resolving a potential proxy contest and granting Kanen certain board access rights.

Quipt Home Medical Corp. announces its Q1 2025 financial results, highlighting a sequential improvement in Adjusted EBITDA despite a slight revenue decrease.

Quipt Home Medical Corp. has entered into a Non-Disclosure and Standstill Agreement with Forager Fund, which includes restrictions on Forager's acquisition of Quipt securities and voting commitments at upcoming shareholder meetings.

Quipt Home Medical Corp. announced its fourth quarter and fiscal year 2024 financial results, highlighting a 16.2% revenue increase for the year and a return to positive sequential organic growth in the fourth quarter.